Clinical trial
The Effect of Hydrodissection for Patients With Carpal Tunnel Syndrome
NCT02991001 is registered in ClinicalTrials.gov with Tri-Service General Hospital (TSGH) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Hydrodissection for Patients With Carpal Tunnel Syndrome
- Lead sponsor
- Tri-Service General Hospital (TSGH)
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2017
- Completion date
- April 15, 2018
- Enrollment
- 34 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.